Tocilizumab significantly reduced 28-day mortality and length of ICU stay in patients with severe COVID-19 pneumonia and low S-spike nAb titers.

The FDA approved Mavyret for the treatment of patients 3 years and older with acute or chronic HCV infection without cirrhosis or with compensated cirrhosis.

The risk of all-cause mortality among older patients with severe CAP was significantly reduced following treatment with glucocorticoids.

Researchers found that during 2020 to 2022, tooth disorders accounted for an annual average of 1,944,000 emergency department visits. HealthDay News — Tooth disorders accounted for an annual average ...

Prepandemic severe spirometric obstruction, spirometric restriction, and increased emphysema on CT are linked to higher risk for severe COVID-19.

More than 460 laid-off employees at the US Centers for Disease Control and Prevention are being rehired, officials said June 11.

Church & Dwight has initiated a recall of all lots within expiry of Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs due to potential microbial contamination.

HHS Secretary Robert F. Kennedy Jr named 8 new members to the CDC’s Advisory Committee on Immunization Practices.

A vaccine critic hired by RFK Jr is reviewing safety data in an effort to revisit debunked claims that vaccines may cause autism.

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

The US Food and Drug Administration says it plans to use artificial intelligence to help speed the approval of new drugs and medical devices.

A 7-day course of antibiotics was noninferior to a 14-day course of antibiotics among patients hospitalized with GN-BSIs.